Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
NVCR

Market Cap: $1.81B

NL

Novocure Ltd

NVCR

NASDAQUSD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin76.13%

EBITDA Margin-19.22%

EBIT Margin-21.30%

Pre-tax Margin-21.84%

Net Profit Margin-21.25%

Earnings Yield-8.26%

Valuation Multiples

Price / Book5.32

Price / Sales2.58

Price / Earnings-11.93

PEG-3.76

Forward PEG0.34

EV / Sales2.78

EV / EBITDA-14.48

EV / Operating Cash Flow1302.41

EV / Free Cash Flow-92.11

Price / Free Cash Flow-85.49

Price / Operating Cash Flow1204.39

Cash Flow & Capital

Free Cash Flow / Share-$0.18

Operating Cash Flow / Share$0.01

Free Cash Flow Yield-1.17%

Capex / Revenue3.24%

Capex / Operating Cash Flow15.14%

Capex / Depreciation4.81

Stock Compensation / Revenue15.64%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio2.89

Quick Ratio2.70

Cash Ratio0.42

Debt / Assets0.29

Debt / Capital0.41

Debt / Equity0.69

Long-Term Debt / Capital0.37

Debt / Market Cap10.85%

Net Debt / EBITDA-1.04

Solvency Ratio-0.29

Financial Leverage2.35

Efficiency & Working Capital

Asset Turnover0.88

Fixed Asset Turnover4.80

Inventory Turnover3.95

Receivables Turnover4.79

Payables Turnover1.28

Days Sales Outstanding76.12

Days Inventory Outstanding92.33

Days Payables Outstanding285.86

Operating Cycle168.45

Cash Conversion Cycle-117.41

Working Capital Turnover1.68

Returns & Quality

Return on Equity-44.00%

Return on Assets-18.68%

Return on Invested Capital-26.15%

ROCE-26.88%

Return on Tangible Assets-18.68%

Operating Return on Assets-19.51%

Income Quality-0.01

Tax Burden0.97

Interest Burden1.03

Balance Sheet & Intrinsic Metrics

Enterprise Value$1.95B

Invested Capital$563.55M

Working Capital$417.81M

Tangible Asset Value$338.09M

Net Current Asset Value$181.42M

Graham Net-Net$0.98

Book Value / Share$2.91

Tangible Book Value / Share$2.91

Cash / Share$3.8

Financial Health Scores

Piotroski Score5

Altman Z-Score0.83

Revenue$699.19M

EBIT$-148.96M

Market Cap$1.8B

Working Capital$417.81M

Retained Earnings$-1.38B

Total Assets$795.19M

Total Liabilities$457.1M